Keytruda 100 MG/4 ML vial 4ML

Ended Awarded Last action

Contract number
SPE2DR26FDAF9
Awardee
Awarding agency
Obligated
$52,474

Award facts

Contract value 100% obligated
$52,473.54 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $52,473.54 delivery order to DMS Pharmaceutical Group Inc. on May 21, 2026, for Keytruda 100 mg/4 mL vial supply under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical is a woman-owned small business serving as the regional prime vendor under PPV-G GEN V's single-award indefinite delivery contract (SPE2DX), which carries a $499.999 billion ceiling and runs through December 31, 2036. Place of performance is Park Ridge, IL. The delivery order is priced on a firm fixed-price basis with an ultimate completion date of June 12, 2026. No set-aside applies.

Quick answers

Who was awarded contract SPE2DR26FDAF9?

SPE2DR26FDAF9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 21, 2026.

How much is contract SPE2DR26FDAF9 worth?

The government has obligated $52,474 on SPE2DR26FDAF9.

Is contract SPE2DR26FDAF9 an order under another contract?

Yes. SPE2DR26FDAF9 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.

Was contract SPE2DR26FDAF9 competed?

The extent of competition for SPE2DR26FDAF9 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award